Equities

Aton SA

Aton SA

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (EUR)0.0085
  • Today's Change0.000 / 1.19%
  • Shares traded1.63m
  • 1 Year change-86.13%
  • Beta1.1671
Data delayed at least 15 minutes, as of Jun 28 2024 16:07 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Aton SA, formerly known as Hybrigenics SA is France-based Company engaged in the biotechnological sector. It specializes in the research and development of drugs intended for cancer treatment and supplies scientific services in the protein interaction field. The Company is specialized in the research and development (R&D) of drugs to fight cancer. It is organized in two units: Hybrigenics Pharma for internal R&D, which develops a research program aimed at such diseases as melanoma and prostate cancer; and Hybrigenics Services for commercial business, mainly engaged in protein interaction information and solutions. Hybrigenics SA’s main development program is based on inecalcitol, a vitamin D analogue, for prostate cancer treatment. It operates through Hybrigenics Corporation and Imaxio.

  • Revenue in EUR (TTM)0.00
  • Net income in EUR-69.16k
  • Incorporated1998
  • Employees17.00
  • Location
    Aton SA850 Boulevard Sebastien BrantILLKIRCH-GRAFFENSTADEN 67400FranceFRA
  • Phone+33 158103800
  • Fax+33 158103849
  • Websitehttps://www.aton-group.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Rapid Nutrition PLC1.03m-1.25m721.43k12.00--582.37--0.7019-0.0036-0.00360.00290.000062.208.3518.9285,648.21-267.55---731.62--22.33---121.76--0.8997--0.5193---44.01--14.52------
Theravet SA-100.00bn-100.00bn1.33m--------------------------------------------------------------
Biophytis SA0.00-17.03m2.38m26.00---------14.37-14.370.00-1.490.00-------100.31-97.52-1,481.81-487.25-----------5.462.27------29.69--14.25--
Aton SA0.00-69.16k3.49m17.00--0.2327-----0.0003-0.00030.000.03610.00-------0.7067-35.48-0.877-48.94-------5,115.72----0.1032--100.00--78.83------
IntegraGen SA12.54m-171.40k3.70m55.00--1.81138.010.2951-0.025-0.0251.900.30411.4712.064.06227,953.30-2.01-1.93-4.78-4.4166.4165.11-1.37-1.511.57--0.3587---4.7812.61-4,783.19------
Medesis Pharma SA0.00-2.79m3.71m10.00---------0.6324-0.63240.00-0.5862------------------------1.14-23.17-----100.00---3.87------
Theranexus SA0.00-6.83m6.39m19.00--2.88-----1.09-1.090.000.28630.00----0.00-70.79-42.66-82.29-47.97-----------1,058.680.6212-------3.97---33.23--
Quantum Genomics SA10.06k-3.17m7.57m3.00--8.67--752.53-0.091-0.0910.00030.01250.0007--0.00163,353.33-23.14-60.77-95.19-102.24-14,205.07-3,548.91-31,520.38-3,374.13---146.530.8615---98.34--87.28------
Acticor Biotech SA0.00-18.65m11.34m24.00--24.14-----1.68-1.680.000.02980.00----0.00-145.59---297.22-------------9.320.9504-------25.94------
NicOx SA3.57m-17.36m13.33m11.00--0.2301--3.73-0.3721-0.37210.07530.91280.0394--1.83324,909.10-19.13-19.22-21.35-20.78-----485.70-370.14----0.3172---54.787.2536.57---13.35--
Ikonisys SA538.56k-2.40m14.98m11.00--0.812--27.82-0.2499-0.24990.0561.750.02461.146.2048,960.00-10.94---12.55--2.72---444.76--0.0818-36.790.1007--68.94---328.57------
Plant Advanced Technologies PAT SA1.68m79.16k15.53m27.00193.241.8126.789.230.07250.07251.547.730.1118-0.41231.6062,278.520.5262-3.530.6534-4.39128.03134.214.71-33.160.4183-15.320.3402--8.568.05119.67-38.00----
Data as of Jun 28 2024. Currency figures normalised to Aton SA's reporting currency: Euro EUR
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.